Connection

Jean-Charles Soria to Lymphoma

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Lymphoma.
Jean-Charles Soria
Connection Strength
0.230
Lymphoma
  1. Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials. Invest New Drugs. 2018 02; 36(1):62-74.
    View in: PubMed
    Score: 0.115
  2. Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies. Br J Cancer. 2017 Jun 06; 116(12):1505-1512.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.